Skip to main content
Skip to main content
JYNT logo

The Joint Corp. (JYNT)

$9.16 +$0.19 (+2.10%) |Strong · 76
Bottom line: BUY — our Council read (73/100) and AI Score (76/100) broadly agree. Strongest single signal: Ken Griffin bullish.
MCap: $130.55M| P/E Ratio: 45.2| Vol: 30.0K| 52-wk range: $7.50 – $13.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

The Joint Corp. (JYNT) trades at $9.16 with AI Score 76/100 (Grade A). The Joint Corp. operates a network of chiropractic clinics across the United States, focusing on affordable and accessible care. Market cap: $130.55M, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
The Joint Corp. operates a network of chiropractic clinics across the United States, focusing on affordable and accessible care. With a strong franchise model and a growing presence, it aims to enhance the chiropractic experience for patients nationwide.

Analyst Coverage for JYNT: JYNT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JYNT against Healthcare peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
BUY 73/100 · A

JYNT: 6/7 perspectives are bullish. Dominant signal: Ken Griffin bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Bullish
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

The Joint Corp. (JYNT) Healthcare & Pipeline Overview

CEOSanjiv Razdan
Employees443
HeadquartersScottsdale, AZ, US
IPO Year2014

The Joint Corp. is a leading provider of chiropractic care in the U.S., operating a network of approximately 700 clinics through corporate and franchise models, emphasizing affordability and accessibility in healthcare services.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for JYNT?

The Joint Corp. presents a compelling investment thesis driven by its unique business model, strong growth trajectory, and favorable market dynamics. With a current market capitalization of $130.55M and a P/E ratio of 45.2, the company has demonstrated resilience in profitability, achieving a profit margin of 5.7% and a gross margin of 78.5%. Key growth catalysts include the expansion of its clinic network, which is expected to reach over 1,000 locations by 2025, driven by its successful franchising strategy. Additionally, the increasing consumer shift towards preventive healthcare and wellness services positions The Joint Corp. to capture a larger market share in the chiropractic sector. However, potential risks include regulatory challenges and competition from other healthcare providers. Overall, The Joint Corp.'s focus on affordable care and strategic growth initiatives make it an interesting player in the healthcare landscape.

Based on FMP financials and quantitative analysis

JYNT Key Highlights

  • Market capitalization of $130.55M reflects solid growth potential in the healthcare sector.
  • P/E ratio of 45.2 indicates investor confidence in future earnings growth.
  • Profit margin of 5.7% showcases operational efficiency within the chiropractic industry.
  • Gross margin of 78.5% significantly exceeds industry averages, highlighting strong service profitability.
  • No dividend yield as the company reinvests earnings for expansion and growth.

Who Are JYNT's Competitors?

JYNT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
SLHGP Skylight Health Group Inc. $12.00 -5.88% 61
TOI The Oncology Institute, Inc. $5.45 +3.22% $544.91M 61
ASTH Astrana Health, Inc. $47.56 -3.27% $2.36B 60
ACHC Acadia Healthcare Company, Inc. $31.54 -1.16% $2.90B 59
SNDA Sonida Senior Living, Inc. $41.18 -2.44% $823.55M 58

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are JYNT's Key Strengths?

  • Established brand with a growing network of clinics.
  • Innovative membership model enhancing customer retention.
  • High gross margins indicating strong operational efficiency.
  • Experienced management team with a clear growth strategy.

What Are JYNT's Weaknesses?

  • Dependence on franchise model may limit control over service quality.
  • No dividend payments may deter income-focused investors.
  • Relatively high P/E ratio compared to industry averages.
  • Limited international presence restricts growth potential.

What Could Drive JYNT Stock Higher?

  • Expansion of clinic network to over 1,000 locations by 2025.
  • Strong consumer demand for affordable chiropractic care driving membership growth.
  • Strategic partnerships with regional developers enhancing franchise operations.
  • Increased marketing efforts aimed at raising consumer awareness of chiropractic benefits.
  • Integration of technology to improve patient engagement and operational efficiency.

What Are the Key Risks for JYNT?

  • Rich valuation — a P/E of 45.2 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
  • Regulatory changes that could impact chiropractic practices and operations.
  • Competition from other healthcare providers and alternative therapies.
  • Economic downturns affecting consumer spending on healthcare services.
  • Dependence on franchisees for consistent service quality and brand reputation.

What Are the Growth Opportunities for JYNT?

  • Expansion of Clinic Network: The Joint Corp. plans to increase its clinic locations from approximately 700 to over 1,000 by 2025. This expansion is expected to drive revenue growth significantly, tapping into underserved markets and increasing brand visibility. The franchise model allows for rapid scaling with lower capital expenditure, making this a strategic growth driver.
  • Membership Model Adoption: The company's membership-based service model is gaining traction, appealing to consumers seeking affordable healthcare solutions. With an increasing focus on preventive care, The Joint Corp. can leverage this model to enhance customer retention and drive recurring revenue, which is critical in a competitive landscape.
  • Increased Consumer Awareness: As awareness of chiropractic benefits grows, particularly in managing chronic pain and enhancing overall wellness, The Joint Corp. stands to benefit. Marketing initiatives aimed at educating potential patients about chiropractic care can expand its customer base, particularly among millennials and health-conscious individuals.
  • Partnerships with Health Plans: Collaborating with health insurance providers to include chiropractic services in their plans can significantly enhance patient access. Such partnerships could lead to increased patient referrals and a broader market reach, positioning The Joint Corp. as a preferred provider in the chiropractic sector.
  • Technological Integration: Investing in telehealth and digital tools can enhance patient engagement and streamline operations. By integrating technology into its service delivery, The Joint Corp. can improve patient experiences and operational efficiency, which is essential for sustaining growth in a rapidly evolving healthcare environment.

What Opportunities Does JYNT Have?

  • Growing consumer awareness of chiropractic benefits.
  • Potential partnerships with health insurance providers.
  • Expansion into underserved markets across the U.S.
  • Integration of technology to enhance service delivery.

What Threats Does JYNT Face?

  • Intense competition from both independent practitioners and larger healthcare networks.
  • Regulatory changes impacting chiropractic practices.
  • Economic downturns affecting consumer spending on healthcare.
  • Negative perceptions or misinformation about chiropractic care.

What Are JYNT's Competitive Advantages?

  • Strong brand recognition in the chiropractic industry.
  • Membership model fosters customer loyalty and recurring revenue.
  • Extensive franchise network allows for rapid expansion with lower capital risk.
  • High gross margins provide a buffer against competitive pricing pressures.
  • Focus on affordability positions The Joint Corp. favorably in a cost-sensitive market.

What Does JYNT Do?

Founded in 2010 and headquartered in Scottsdale, Arizona, The Joint Corp. has established itself as a prominent player in the chiropractic care industry. The company develops, owns, operates, supports, and manages chiropractic clinics, primarily through two segments: Corporate Clinics and Franchise Operations. Since its inception, The Joint Corp. has focused on making chiropractic care more accessible and affordable for patients across the United States. As of March 1, 2022, it operated approximately 700 locations nationwide, reflecting its robust growth strategy and commitment to expanding its footprint. The company's business model leverages direct ownership, management arrangements, franchising, and partnerships with regional developers, allowing it to scale efficiently while maintaining a strong brand presence. The Joint Corp. differentiates itself by offering a membership-based model that provides patients with unlimited access to chiropractic services at a flat monthly fee, catering to the increasing demand for cost-effective healthcare solutions. This innovative approach not only enhances patient loyalty but also positions the company favorably in a competitive landscape characterized by rising healthcare costs and a growing emphasis on preventive care. The Joint Corp.'s commitment to quality care and patient satisfaction has garnered a loyal customer base, making it a leader in the chiropractic sector.

What Products and Services Does JYNT Offer?

  • Develop and operate chiropractic clinics across the United States.
  • Provide affordable chiropractic care through a membership-based model.
  • Offer a range of services including spinal adjustments and wellness care.
  • Support franchise operations to expand the clinic network.
  • Focus on patient satisfaction and quality care.
  • Utilize a combination of corporate ownership and franchising for growth.

How Does JYNT Make Money?

  • Revenue generated through membership fees for unlimited chiropractic services.
  • Franchise fees and royalties from franchisees operating under The Joint Corp. brand.
  • Direct ownership of corporate clinics contributing to overall revenue.
  • Management agreements with regional developers to expand clinic presence.
  • Cost-effective operations due to high gross margins from service delivery.

What Industry Does JYNT Operate In?

The healthcare industry, particularly the chiropractic care segment, is witnessing significant growth due to increasing awareness of alternative medicine and preventive health measures. The U.S. chiropractic services market is projected to reach approximately $18 billion by 2026, driven by rising consumer demand for non-invasive treatments and holistic wellness approaches. The Joint Corp. is well-positioned within this expanding market, leveraging its franchise model to capitalize on regional growth opportunities while facing competition from both independent practitioners and larger healthcare networks. The trend towards integrated care models further enhances the relevance of chiropractic services in overall patient health management.

Who Are JYNT's Key Customers?

  • Individuals seeking affordable chiropractic care for pain management.
  • Health-conscious consumers interested in preventive wellness services.
  • Franchisees looking to operate under a recognized brand in the healthcare sector.
  • Patients with chronic pain conditions requiring ongoing treatment.
  • Families seeking accessible healthcare options for all members.
AI Confidence: 72% Updated: May 10, 2026

ROE 17%Key Financial Metrics

Return on equity for The Joint Corp. stands at 16.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.6%, showing how much profit it generates from its asset base. JYNT trades at a trailing price-to-earnings ratio of 45.19, above the Healthcare sector average of ~23x. Its free cash flow yield is 2.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.61 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.5%, the inverse of the P/E and a quick read on earnings relative to price.

The Joint Corp. (JYNT) Valuation Context

Valued at $130.55M, JYNT is classified as a micro-cap stock. Relative to its peer group, JYNT's quantitative score of 76/100 is above the peer average of 62/100.

Company Profile

The Joint Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Scottsdale, US. The company is led by CEO Sanjiv Razdan. JYNT has traded publicly since 2014.

F-Score 8/9Financial Health

The Joint Corp.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.67 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project The Joint Corp. revenue of about $60.3M for fiscal 2026, with EPS near $0.28. The estimate reflects 3 contributing analysts.

JYNT Financials

Fundamental Snapshot

Revenue Growth (FY)
+5.2%
Net Income Growth (FY)
+150.2%
EPS Growth (FY)
+148.7%
Free Cash Flow Growth (FY)
-95.9%
P/E (TTM)
39.3
Return on Equity (TTM)
+16.9%
Current Ratio
1.6
EV/EBITDA (TTM)
36.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • The recent insider buying suggests confidence in The Joint Corp.'s growth potential, indicating that those closest to the company believe in its future.
  • Community sentiment has turned positive, with many investors discussing the company's expansion strategy and its impact on revenue growth.
  • The healthcare sector's increasing focus on alternative treatments aligns well with The Joint's chiropractic services, enhancing market relevance.
  • Recent partnerships and collaborations have been highlighted, showcasing The Joint's proactive approach to expanding its service offerings and customer base.

Bear Case

  • Concerns over rising operational costs have emerged, leading some investors to question the sustainability of profit margins in the near term.
  • Negative sentiment has been noted in discussions around competition, with some community members expressing worries about market saturation in the chiropractic space.
  • Regulatory challenges in the healthcare industry could pose risks, causing hesitation among potential investors regarding future growth.
  • Recent earnings reports have shown mixed results, leading to skepticism about whether the company can maintain its upward trajectory amidst economic uncertainties.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026

JYNT Latest News

JYNT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for JYNT.

Price Targets

Wall Street price target analysis for JYNT.

JYNT MoonshotScore

76/100

What does this score mean?

The MoonshotScore rates JYNT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Sanjiv Razdan

CEO

Sanjiv Razdan has extensive experience in the healthcare sector, having held various leadership roles in both operational and strategic capacities. He has a strong background in business management and has been instrumental in driving growth initiatives at The Joint Corp. since his appointment as CEO.

Track Record: Under Sanjiv Razdan's leadership, The Joint Corp. has expanded its clinic network significantly and improved operational efficiencies, contributing to the company's strong financial performance. His focus on customer satisfaction and innovative service delivery has positioned the company for continued growth.

The Joint Corp. Healthcare Stock: Key Questions Answered

What does The Joint Corp. do?

The Joint Corp. specializes in developing and operating chiropractic clinics across the United States. It offers affordable chiropractic care through a unique membership model, allowing patients unlimited access to services for a flat monthly fee. The company operates both corporate-owned clinics and franchises, focusing on enhancing patient experience and accessibility.

What do analysts say about JYNT stock?

Analysts generally view JYNT stock positively, highlighting its innovative business model and growth potential. Key valuation metrics, such as a P/E ratio of 45.2, indicate strong investor confidence. Analysts also consider the company's strategic expansion plans and increasing consumer demand for chiropractic services as significant growth factors.

What are the main risks for JYNT?

The main risks for The Joint Corp. include regulatory challenges that could affect chiropractic practices, as well as competition from other healthcare providers. Economic downturns may impact consumer spending on healthcare services, and the company's reliance on franchisees could pose risks to service quality and brand reputation. These factors require careful monitoring as the company continues to grow.

What are the key factors to evaluate for JYNT?

The Joint Corp. (JYNT) holds an AI score of 76/100 (high). P/E: 45.2x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does JYNT data refresh on this page?

JYNT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven JYNT's recent stock price performance?

The Joint Corp. (JYNT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand with a growing network of clinics. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider JYNT overvalued or undervalued right now?

The Joint Corp. (JYNT) trades at 45.2x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying JYNT?

Before investing in The Joint Corp. (JYNT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information as of May 2026.
Data Sources

Popular Stocks